Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor Antagonist
- 1 September 2005
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 48 (3) , 471-477
- https://doi.org/10.1016/j.eururo.2005.05.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An investigation of dose titration with darifenacin, an M3‐selective receptor antagonistBJU International, 2005
- ASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACINJournal of Urology, 2005
- Cholinergic Stimulation of Salivary Secretion Studied with M1 and M3 Muscarinic Receptor Single- and Double-Knockout MiceMolecular Pharmacology, 2004
- Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activityEuropean Journal of Neuroscience, 2003
- Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imagingJournal of Neurology, Neurosurgery & Psychiatry, 2003
- M3 muscarinic receptors mediate contraction of human urinary bladderBritish Journal of Pharmacology, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- The minor population of M3‐receptors mediate contraction of human detrusor muscle in vitroJournal of Autonomic Pharmacology, 2001
- The Problems of Anticholinergic Adverse Effects in Older PatientsDrugs & Aging, 1993
- Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factorsActa Neurologica Scandinavica, 1990